Bruker price target raised to $81 from $63 at Stifel

Stifel raised the firm’s price target on Bruker to $81 from $63 and keeps a Hold rating on the shares. The company’s Q4 upside and solid 2024 guidance were not surprising, but management also pulled forward its 2026 medium-term outlook by one year, implicating continued strong top-line momentum and significant rebound in margins, the analyst tells investors. While there may be some debate over the shape of the company’s performance next year, it has become difficult to argue against the relative strength of the business or its valuation case, Stifel adds.